Sana Biotechnology, Inc. (SANA) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 103 transactions totaling $42.1M, demonstrating a bullish sentiment with $19.3M in net insider flow. The most recent transaction on Dec 15, 2025 involved a transaction of 873 shares valued at $4.6K.
No significant insider buying has been recorded for SANA in the recent period.
No significant insider selling has been recorded for SANA in the recent period.
Based on recent SEC filings, insider sentiment for SANA is bullish with an Insider Alignment Score of 73/100 and a net flow of $19.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Sana Biotechnology, Inc. (SANA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading SANA stock, having executed 103 transactions in the past 90 days. The most active insider is Venture Fund X, L.p. Arch (Executive), who has made 7 transactions totaling $10.0M.
Get notified when executives and directors at SANA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | D. Wyrick Susan | Executive | Payment | 873 | $5.22 | $4.6K | |
| Dec 13, 2025 | D. Wyrick Susan | Executive | Option Exercise | 3,400 | $N/A | $0 | |
| Dec 4, 2025 | D. Wyrick Susan | Executive | Payment | 2,565 | $4.44 | $11.4K | |
| Dec 3, 2025 | D. Wyrick Susan | Executive | Option Exercise | 10,000 | $N/A | $0 | |
| Oct 6, 2025 | Edgar Bishop Hans | Executive | Award | 5,628 | $N/A | $0 | |
| Jul 7, 2025 | Edgar Bishop Hans | Executive | Award | 7,842 | $N/A | $0 | |
| Jun 4, 2025 | D. Wyrick Susan | Executive | Payment | 2,567 | $2.32 | $6.0K | |
| Jun 3, 2025 | D. Wyrick Susan | Executive | Option Exercise | 10,000 | $N/A | $0 | |
| Sep 25, 2024 | Mulligan Richard | Executive | Sale | 150,000 | $3.89 | $583.5K | Large10b5-1 |
| Sep 24, 2024 | Mulligan Richard | Executive | Sale | 150,000 | $4.08 | $612.0K | Large10b5-1 |
| Jul 5, 2024 | Edgar Bishop Hans | Executive | Award | 4,911 | $N/A | $0 | |
| Apr 5, 2024 | Edgar Bishop Hans | Executive | Award | 2,774 | $N/A | $0 | |
| Mar 8, 2024 | Y. Yang Patrick | Executive | Sale | 25,000 | $9.45 | $236.3K | |
| Feb 8, 2024 | Fund X, L.p. Arch Venture | Executive | Purchase | 363,637 | $5.50 | $2.0M | Large |
| Feb 8, 2024 | Fund X, L.p. Arch Venture | Executive | Purchase | 727,272 | $5.50 | $4.0M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 11 | $30.7M | 72.6% |
Sale(S) | 27 | $11.4M | 26.9% |
Exercise(M) | 9 | $170.9K | 0.4% |
Award(A) | 22 | $23.3K | 0.1% |
Payment(F) | 3 | $21.9K | 0.1% |
Other(J) | 7 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Conversion(C) | 22 | $0 | 0.0% |
Insiders at Sana Biotechnology, Inc. are accumulating shares at an accelerated pace. With 18 insiders making 103 transactions totaling $30.7M in purchases versus $11.4M in sales, the net buying activity of $19.3M signals strong executive confidence. Venture Fund X, L.p. Arch (Executive) leads the buying activity with $10.0M in transactions across all time.